NATIONAL BREAST CANCER COALITION FUND

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$8.2M

Filings

165

Firms Hired

Active Period

1999–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$178,353	6	2
2025	$309,000	8	2
2024	$295,362	8	2
2023	$289,488	8	2
2022	$229,153	8	2
2021	$233,389	8	2
2020	$274,708	7	2
2019	$212,031	8	2
2018	$165,828	8	2
2017	$356,283	9	2
2016	$437,280	9	2
2015	$472,035	10	2
2014	$248,231	5	2
2013	$197,326	8	2
2012	$326,539	8	2
2011	$450,000	8	2
2010	$500,000	8	2
2009	$666,197	11	2
2008	$494,113	5	1
2007	$375,000	2	1
2006	$218,359	2	1
2005	$382,440	2	1
2004	$400,300	2	1
2003	$149,000	1	1
2002	$80,000	1	1
2001	$80,000	1	1
2000	$100,000	2	1
1999	$40,000	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
NATIONAL BREAST CANCER COALITION FUND	$8,160,415	98
NVG, LLC	—	67

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	149
HOUSE OF REPRESENTATIVES	117
White House Office	76
Health & Human Services, Dept of (HHS)	72
Defense, Dept of (DOD)	56
Centers For Medicare and Medicaid Services (CMS)	55
Natl Institutes of Health (NIH)	53
Centers For Disease Control & Prevention (CDC)	52
Food & Drug Administration (FDA)	51
Defense Advanced Research Projects Agency (DARPA)	33
Executive Office of the President (EOP)	5
Office of Management & Budget (OMB)	5
President of the U.S.	5
Government Accountability Office (GAO)	3
Office of the Vice President of the United States	3
Office of Science & Technology Policy (OSTP)	1
Vice President of the U.S.	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Defense	Defense	103
Health Issues	Health Issues	100
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	63
Budget/Appropriations	Budget/Appropriations	48
Medicare/Medicaid	Medicare/Medicaid	21
Government Issues	Government Issues	2

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

S. 3442119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.3442

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

S. 3442119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.3442

Show 21 more cited filings

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · first_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

S. 3442119th Congress

Metastatic Breast Cancer Access to Care Act

2026 · first_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048/S.3442 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.3442

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2025 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2025 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2025 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

H.R. 2048119th Congress

Metastatic Breast Cancer Access to Care Act

2025 · first_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.2048 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.2048

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R. 549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2024 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.663/H.R. 549 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · third_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · second_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 549118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · first_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.549

S. 663118th Congress

Metastatic Breast Cancer Access to Care Act

2023 · first_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

H.R.549/S.663- Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: S.663

H.R. 3183117th Congress

Metastatic Breast Cancer Access to Care Act

2022 · fourth_quarter · Firm: NVG, LLC

Open original LDA filing ↗

Cited source text and reported amounts

S.1312/H.R.3183 - Metastatic Breast Cancer Access to Care Act.

Client expense: — · Firm income: $10,000

Matched citations: H.R.3183

Source: Senate LDA

NATIONAL BREAST CANCER COALITION FUND — Lobbying Disclosure | Poliscope